Skip to main content
logo
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
6.63
+0.30 (4.83%)
At close: Sep 18, 2026, 4:00 PM EDT
6.54
-0.08 (-1.27%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
25631597327
Market Cap Growth
1064.65%107.69%-82.20%-84.31%-70.26%-
Enterprise Value
18-2215--
Last Close Price
6.632.4629.894258.9839616.7437396.84

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--2.69---
PB Ratio
0.900.330.40-1.39-485.22192.35
P/TBV Ratio
1.490.330.40--192.35

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
----0.95--
Net Debt / Equity Ratio
-0.44-0.44-0.91-0.886.66-1.03
Net Debt / EBITDA Ratio
1.201.201.68-3.53--
Net Debt / FCF Ratio
0.910.911.64-3.290.841.26
Quick Ratio
12.1212.1210.550.060.8313.62
Current Ratio
14.6214.6211.040.090.8913.90
Return on Equity (ROE)
-58.62%-58.62%---468.63%-
Return on Assets (ROA)
-31.33%-31.33%-54.20%-126.35%-123.25%-
Return on Capital Employed (ROCE)
-36.80%-36.80%-54.50%25.10%1613.80%-109.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-27.45%-122.95%37.25%-335.16%-3.30%-0.57%
FCF Yield
-32.23%-144.34%-137.84%-19.33%-1.64%-0.43%
Buyback Yield / Dilution
-1688.07%-1688.07%----
SEC Filings: 10-K · 10-Q